These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33417692)

  • 21. Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease.
    Goldenberg I; Kutyifa V; Zareba W; Huang DT; Rosero SZ; Younis A; Schuger C; Gao A; McNitt S; Polonsky B; Steinberg JS; Goldenberg I; Aktas MK
    Front Cardiovasc Med; 2023; 10():1237118. PubMed ID: 37680559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Haigney MC; Zareba W; Gentlesk PJ; Goldstein RE; Illovsky M; McNitt S; Andrews ML; Moss AJ;
    J Am Coll Cardiol; 2004 Oct; 44(7):1481-7. PubMed ID: 15464332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of ventricular arrhythmias following implantable cardioverter-defibrillator generator change in patients with recovered ejection fraction: Implications for shared decision-making.
    Chang DD; Pantlin PG; Benn FA; Ryan Gullatt T; Bernard ML; Elise Hiltbold A; Khatib S; Polin GM; Rogers PA; Velasco-Gonzalez C; Morin DP
    J Cardiovasc Electrophysiol; 2023 Jun; 34(6):1405-1414. PubMed ID: 37146210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrhythmic and Mortality Outcomes Among Ischemic Versus Nonischemic Cardiomyopathy Patients Receiving Primary ICD Therapy.
    Narins CR; Aktas MK; Chen AY; McNitt S; Ling FS; Younis A; Zareba W; Daubert JP; Huang DT; Rosero S; Kutyifa V; Goldenberg I
    JACC Clin Electrophysiol; 2022 Jan; 8(1):1-11. PubMed ID: 34454875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival After Implantable Cardioverter-Defibrillator Shocks.
    Aktaş MK; Younis A; Zareba W; Kutyifa V; Klein H; Daubert JP; Estes M; McNitt S; Polonsky B; Goldenberg I
    J Am Coll Cardiol; 2021 May; 77(20):2453-2462. PubMed ID: 34016257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced risk of life-threatening ventricular tachyarrhythmias with cardiac resynchronization therapy: relationship to left ventricular ejection fraction.
    Kutyifa V; Moss AJ; Solomon SD; McNitt S; Aktas MK; Barsheshet A; Merkely B; Zareba W; Goldenberg I
    Eur J Heart Fail; 2015 Sep; 17(9):971-8. PubMed ID: 26173635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
    Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of MADIT-II Risk Stratification Score Among Nationwide Registry of Heart Failure Patients With Primary Prevention Implantable Cardiac Defibrillators or Resynchronization Therapy Devices.
    Rav-Acha M; Wube O; Brodie OT; Michowitz Y; Ilan M; Ovdat T; Klempfner R; Suleiman M; Goldenberg I; Glikson M
    Am J Cardiol; 2024 Jan; 211():17-28. PubMed ID: 37879381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W; Hoffmann J Jü; Müller HH; Maisch B
    J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyssynchrony and the risk of ventricular arrhythmias.
    Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Dhar R; Alsheikh-Ali AA; Estes NA; Moss AJ; Zareba W; Daubert JP; Greenberg H; Case RB; Kent DM
    Heart Rhythm; 2008 Jun; 5(6):807-13. PubMed ID: 18534364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.
    Sesselberg HW; Moss AJ; McNitt S; Zareba W; Daubert JP; Andrews ML; Hall WJ; McClinitic B; Huang DT;
    Heart Rhythm; 2007 Nov; 4(11):1395-402. PubMed ID: 17954398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional Longitudinal Deformation Improves Prediction of Ventricular Tachyarrhythmias in Patients With Heart Failure With Reduced Ejection Fraction: A MADIT-CRT Substudy (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
    Biering-Sørensen T; Knappe D; Pouleur AC; Claggett B; Wang PJ; Moss AJ; Solomon SD; Kutyifa V
    Circ Cardiovasc Imaging; 2017 Jan; 10(1):. PubMed ID: 28003221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator.
    Aktaş MK; Younis A; Saxena S; Diamond A; Ojo A; Kutyifa V; Steiner H; Steinberg JS; Zareba W; McNitt S; Polonsky B; Rosero SZ; Huang DT; Goldenberg I
    JACC Clin Electrophysiol; 2023 Jul; 9(7 Pt 1):979-988. PubMed ID: 36752470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.